Compare ENOV & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENOV | AXGN |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2008 | 2013 |
| Metric | ENOV | AXGN |
|---|---|---|
| Price | $24.00 | $28.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $48.75 | $36.11 |
| AVG Volume (30 Days) | ★ 1.1M | 750.9K |
| Earning Date | 06-01-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | $6.49 | $19.81 |
| Revenue Next Year | $5.56 | $16.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $21.00 | $9.22 |
| 52 Week High | $40.70 | $36.00 |
| Indicator | ENOV | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 51.45 | 30.31 |
| Support Level | $21.30 | $23.00 |
| Resistance Level | $26.41 | $34.26 |
| Average True Range (ATR) | 1.21 | 1.40 |
| MACD | 0.23 | -0.63 |
| Stochastic Oscillator | 52.80 | 6.55 |
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.